WGBH Openvault

FRONTLINE; Breast Implants on Trial

License Clip

More material is available from this program at the WGBH Archive. If you are a researcher interested in accessing the collection at WGBH, please email archive_requests@wgbh.org.

Undigitized item: Request Digitization

Untranscribed item: Request Transcription

Breast Implants on Trial
Program Number


Series Description

Premiered January 1983 Since January 1983, FRONTLINE has served as American public television's - PBS - flagship public affairs series. Hailed upon its television broadcast debut as "the last best hope for broadcast documentaries," FRONTLINE's stature over 23 years is reaffirmed each week through incisive documentaries covering the scope and complexity of the human experience. Series release date: 1/1983

Program Description

Some 450,000 women are part of the proposed global settlement against U.S. breast implant manufacturers in the largest lawsuit in history. Many claim that they have contracted a wide range of silicone-related diseases, but recent medical studies conducted by the nation's premier researchers have failed to find any evidence that silicone breast implants are dangerous. As Congress actively examines the powers of the FDA and the possibilities of tort reform, "Frontline" looks at the enormous stakes involved in the clash between biomedical science and the nation's most powerful litigators.



Asset Type

Broadcast program

Media Type


Public Affairs
Chicago: “FRONTLINE; Breast Implants on Trial,” WGBH Media Library & Archives, accessed December 17, 2018, http://openvault.wgbh.org/catalog/V_D0D0A26417D84D91A7B8F0052F7A9D17.
MLA: “FRONTLINE; Breast Implants on Trial.” WGBH Media Library & Archives. Web. December 17, 2018. <http://openvault.wgbh.org/catalog/V_D0D0A26417D84D91A7B8F0052F7A9D17>.
APA: FRONTLINE; Breast Implants on Trial. Boston, MA: WGBH Media Library & Archives. Retrieved from http://openvault.wgbh.org/catalog/V_D0D0A26417D84D91A7B8F0052F7A9D17
If you have more information about this item, we want to know! Please contact us, including the URL.